Identifying Haemoglobinopathy Carriers in Portugal: Challenges and Considerations from a Primary Health Care Perspective
DOI:
https://doi.org/10.20344/amp.20812Keywords:
Hemoglobinopathies/diagnosis, Portugal, Primary Health CareAbstract
N/a.
Downloads
References
Santos D, Barreto M, Kislaya I, Mendonça J, Machado MP, Lopes P, et al. Prevalence rate of thalassemia carriers among individuals with microcytosis or hypochromia in Portugal. Acta Med Port. 2023;36:467-74. DOI: https://doi.org/10.20344/amp.19162
Martinez PA, Angastiniotis M, Eleftheriou A, Gulbis B, Pereira MM, Petrova-Benedicts R, et al. Haemoglobinopathies in Europe: health & migration policy perspectives. Orphanet J Rare Dis. 2014;9:97. DOI: https://doi.org/10.1186/1750-1172-9-97
World Health Organization. Executive Board, 118th Session. Thalassaemia and other haemoglobinopathies: document EB118/5. Geneva: WHO; 2006.
van Vliet ME, Kerkhoffs JL, Hartevel CL, Houwink EJ. Hemoglobinopathy prevention in primary care: a reflection of underdetection and difficulties with accessibility of medical care, a quantitative study. Eur J Hum Genet. 2022;30:790-4. DOI: https://doi.org/10.1038/s41431-022-01051-8
Cataldo F. Immigration and changes in the epidemiology of hemoglobin disorders in Italy: an emerging public health burden. Ital J Ped. 2012;38:32. DOI: https://doi.org/10.1186/1824-7288-38-32
Direção-Geral da Saúde. Prevenção das formas graves de hemoglobinopatia: Circular Normativa n.º 18/DSMIA, de 07/09/2004. Lisboa: DGS; 2004.
Lopes SM, Machado R. Relatório de imigração, fronteiras e asilo 2022. Lisboa: Serviço de Estrangeiros e Fronteiras; 2023.
Costa SM, Sobral M, Delgadinho G. Hemoglobinopatias em Portugal e a intervenção do médico de família. Rev Por Med Ger Fam. 2016;32:416-24. DOI: https://doi.org/10.32385/rpmgf.v32i6.11963
Instituto Nacional de Saúde Doutor Ricardo Jorge. Rastreio Neonatal: 83.436 recém-nascidos estudados em 2022. [consultado 2023 nov 12]. Disponível em: https://www.insa.min-saude.pt/rastreio-neonatal-83-436-recem-nascidos-estudados-em-2022/.
Lobitz S, Telfer P, Cela E, Allaf B, Angastiniotis M, Johansson CB, et al. Newborn screening for sickle cell disease in Europe: recommendations from a Pan-European Consensus Conference. Br J Haematol. 2018;183:648-60. DOI: https://doi.org/10.1111/bjh.15600
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Acta Médica Portuguesa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.
